Exact Mass: 480.187
Exact Mass Matches: 480.187
Found 217 metabolites which its exact mass value is equals to given mass value 480.187
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5alpha-Pregnan-3beta,20alpha-diol disulfate
5alpha-Pregnan-3beta,20alpha-diol disulfate, also known as 5α-pregnan-3β,20α-ylene sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20alpha-diol disulfate is an extremely strong acidic compound (based on its pKa). 5alpha-Pregnan-3beta,20alpha-diol disulfate can be found in feces. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5alpha-Pregnan-3beta,20beta-diol disulfate
5alpha-Pregnan-3beta,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
5alpha-Pregnan-3alpha,20beta-diol disulfate
5alpha-Pregnan-3alpha,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3alpha,20beta-diol disulfate is possibly neutral. 5alpha-Pregnan-3alpha,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is an acylcarnitine. More specifically, it is an (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
[10,13-Dimethyl-17-(1-sulfooxyethyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
beclomethasone propionate
trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran
(aS)-(5R,7R)-5,6,7,8-tetrahydro-13,14-dimethoxy-7-methyl-6-methylene-1,3-benzodioxolo[5,6:3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl (2Z)-2-methylbut-enoate|schisandrene A
2-Hydroxy-5-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-4,6-dimethylbenzoic acid 3-hydroxy-2,4,5-trimethylphenyl ester
Phe Asp Ala Glu
[3-(13-methyltetradecyl)-5-sulfooxyphenyl] hydrogen sulfate
Ala Asp Glu Phe
Ala Asp Phe Glu
Ala Glu Asp Phe
Ala Glu Phe Asp
Ala Phe Asp Glu
Ala Phe Glu Asp
Ala Asn Asn Tyr
Ala Asn Tyr Asn
Ala Tyr Asn Asn
Cys Cys Lys Gln
Cys Cys Gln Lys
Cys Lys Cys Gln
Cys Lys Gln Cys
Cys Gln Cys Lys
Cys Gln Lys Cys
Asp Ala Glu Phe
Asp Ala Phe Glu
Asp Glu Ala Phe
Asp Glu Phe Ala
Asp Phe Ala Glu
Asp Phe Glu Ala
Asp Pro Ser Tyr
Asp Pro Tyr Ser
Asp Ser Pro Tyr
Asp Ser Tyr Pro
Asp Tyr Pro Ser
Asp Tyr Ser Pro
Glu Ala Asp Phe
Glu Ala Phe Asp
Glu Asp Ala Phe
Glu Asp Phe Ala
Glu Glu Phe Gly
Glu Glu Gly Phe
Glu Phe Ala Asp
Glu Phe Asp Ala
Glu Phe Glu Gly
Glu Phe Gly Glu
Glu Gly Glu Phe
Glu Gly Phe Glu
Glu Met Thr Thr
Glu Thr Met Thr
Glu Thr Thr Met
Phe Ala Asp Glu
Phe Ala Glu Asp
Phe Asp Glu Ala
Phe Glu Ala Asp
Phe Glu Asp Ala
Phe Glu Glu Gly
Phe Glu Gly Glu
Phe Gly Glu Glu
Phe Asn Asn Ser
Phe Asn Ser Asn
Phe Ser Asn Asn
Gly Glu Glu Phe
Gly Glu Phe Glu
Gly Phe Glu Glu
Gly His His Met
Gly His Met His
Gly Met His His
Gly Asn Gln Tyr
Gly Asn Tyr Gln
Gly Gln Asn Tyr
Gly Gln Tyr Asn
Gly Tyr Asn Gln
Gly Tyr Gln Asn
His Gly His Met
His Gly Met His
His His Gly Met
His His Met Gly
His Met Gly His
His Met His Gly
Lys Cys Cys Gln
Lys Cys Gln Cys
Lys Gln Cys Cys
Met Glu Thr Thr
Met Gly His His
Met His Gly His
Met His His Gly
Met Thr Glu Thr
Met Thr Thr Glu
Asn Ala Asn Tyr
Asn Ala Tyr Asn
Asn Phe Asn Ser
Asn Phe Ser Asn
Asn Gly Gln Tyr
Asn Gly Tyr Gln
Asn Asn Ala Tyr
Asn Asn Phe Ser
Asn Asn Ser Phe
Asn Asn Tyr Ala
Asn Gln Gly Tyr
Asn Gln Tyr Gly
Asn Ser Phe Asn
Asn Ser Asn Phe
Asn Tyr Ala Asn
Asn Tyr Gly Gln
Asn Tyr Asn Ala
Asn Tyr Gln Gly
Pro Asp Ser Tyr
Pro Asp Tyr Ser
Pro Ser Asp Tyr
Pro Ser Tyr Asp
Pro Tyr Asp Ser
Pro Tyr Ser Asp
Gln Cys Cys Lys
Gln Cys Lys Cys
Gln Gly Asn Tyr
Gln Gly Tyr Asn
Gln Lys Cys Cys
Gln Asn Gly Tyr
Gln Asn Tyr Gly
Gln Tyr Gly Asn
Gln Tyr Asn Gly
Ser Asp Pro Tyr
Ser Asp Tyr Pro
Ser Phe Asn Asn
Ser Asn Phe Asn
Ser Asn Asn Phe
Ser Pro Asp Tyr
Ser Pro Tyr Asp
Ser Tyr Asp Pro
Ser Tyr Pro Asp
Thr Glu Met Thr
Thr Glu Thr Met
Thr Met Glu Thr
Thr Met Thr Glu
Thr Thr Glu Met
Thr Thr Met Glu
Tyr Ala Asn Asn
Tyr Asp Pro Ser
Tyr Asp Ser Pro
Tyr Gly Asn Gln
Tyr Gly Gln Asn
Tyr Asn Ala Asn
Tyr Asn Gly Gln
Tyr Asn Asn Ala
Tyr Asn Gln Gly
Tyr Pro Asp Ser
Tyr Pro Ser Asp
Tyr Gln Gly Asn
Tyr Gln Asn Gly
Tyr Ser Asp Pro
Tyr Ser Pro Asp
[1,1-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-5-yl ester
Sulfatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-(4-Chloro-3-(3-(1-hydroxycycloheptyl)propanoyl)phenyl)-4-((2R)-2-hydroxy-3-methoxy-propyl)-1,2,4-triazine-3,5-dione
CE-224535 is a selective P2X7 receptor antagonist.
1,2,3-Propanetricarboxylic acid, 2-[(trimethylsilyl)oxy]-, tris(trimethylsilyl) ester
[9-Chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-1-yl] propanoate
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
N,N,N-tris(3-pyridylmethyl)benzene-1,3,5-tricarboxamide
6-amino-1,3-diphenyl-4-(3,4,5-trimethoxyphenyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile
4-[4-Oxo-2-[[2-oxo-2-[(phenylmethyl)amino]ethyl]thio]-3-quinazolinyl]-1-piperidinecarboxylic acid ethyl ester
N,N,N-tris(4-pyridylmethyl)benzene-1,3,5-tricarboxamide
7-[4-[4-(2,5-dimethylphenyl)-1-piperazinyl]-4-oxobutyl]-6-sulfanylidene-5H-[1,3]dioxolo[4,5-g]quinazolin-8-one
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methylanilino)-N-(2-furanylmethyl)-2-(3-pyridinyl)acetamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propyl-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propyl-N-(2-thiazolyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
(20R)-5alpha-pregnane-3,20-diyl bis(hydrogen sulfate)
(2S,3R,4S)-3-ethenyl-4-[(E)-2-[1-(2-hydroxyethyl)pyridin-1-ium-3-yl]ethenyl]-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
Pregnane-3,20-diol 3,20-disulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones